Diagnostic value of striatal (18)F-FP-DTBZ PET in Parkinson’s disease

BACKGROUND: (18)F-FP-DTBZ has been proven as a biomarker for quantifying the concentration of presynaptic vesicular monoamine transporter 2 (VMAT2). However, its clinical application is still limited. OBJECTIVES: To evaluate the difference in dopaminergic integrity between patients with Parkinson’s...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Xiu-Lin, Liu, Shu-Ying, Barret, Olivier, Tamagnan, Gilles D., Qiao, Hong-Wen, Song, Tian-Bin, Lu, Jie, Chan, Piu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Neuroscience
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9355024/
https://www.ncbi.nlm.nih.gov/pubmed/35936768
http://dx.doi.org/10.3389/fnagi.2022.931015

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9355024/
https://www.ncbi.nlm.nih.gov/pubmed/35936768
http://dx.doi.org/10.3389/fnagi.2022.931015

Ejemplares similares